+86-577-67378828
canaan@chinacanaan.com High-Containment Solutions for
HPAPI Manufacturing
OEB4/OEB5 Compliant Systems. Empowering global pharmaceutical manufacturers with end-to-end containment from concept design to validation.
Why High-Containment Matters in HPAPI Production
Pharmaceutical containment plays a critical role in modern pharmaceutical manufacturing, especially as highly potent active pharmaceutical ingredients (HPAPI) and high-potency drug development continue to increase. During dispensing, granulation, compression, and coating, even trace exposure to potent compounds can pose serious health risks to operators.
Regulatory frameworks such as GMP, FDA, and EMA require pharmaceutical containment solutions that effectively control occupational exposure and prevent cross-contamination. According to OEB (Occupational Exposure Band) classifications, products in OEB4 and OEB5 categories must be manufactured using high-containment systems rather than relying solely on personal protective equipment or local dust extraction.
High-containment manufacturing is therefore not simply about dust control—it is a systematic approach to operator safety, product integrity, and regulatory compliance across the entire pharmaceutical process.
HPAPIs include cytotoxic or anticancer agents, hormones, and highly toxic or sensitizing compounds. These compounds are defined by their high pharmacological potency even at low doses.
Key Challenges in Highly Potent API Manufacturing - and How Containment Solves Them
Occupational exposure and HPAPI safety
Highly potent API manufacturing presents significant HPAPI safety challenges due to frequent operator interaction and complex material flows. Pharmaceutical containment systems using isolators, negative-pressure control, and RTP or α/β valves effectively reduce operator exposure during high-risk operations.
Material potency and dose control
Highly potent APIs require handling at extremely low dosage levels, where even minor deviations or material loss can result in significant safety and quality risks. Containment systems enable precise dosing and closed handling, reducing exposure while maintaining process accuracy.
Cross-contamination and cleaning validation
High-potency pharmaceutical development often involves multiple products on shared lines, increasing cross-contamination risk. Fully enclosed washing-filtration-drying systems combined with CIP/SIP enable validated, repeatable cleaning while maintaining containment.
Transfer, sampling, and maintenance risks
In a high-containment API process, secondary exposure often occurs during material transfer, sampling, or equipment servicing. Integrated containment solutions using vacuum transfer and closed sampling systems ensure containment continuity.
By addressing these challenges at the process level, pharmaceutical containment becomes a fundamental part of high-potency drug development.
High-Containment API Process & Integrated Production Lines
Effective high-containment API processes depend on system-level industrial containment solutions, not isolated equipment upgrades. Canaan designs integrated pharmaceutical containment systems covering the entire solid dosage workflow:
- Containment isolator dispensing and charging
- Wet or dry granulation with sealed feeding and discharge
- Vacuum-based material transfer and closed intermediate storage
- Compression, capsule filling, and coating under continuous containment
- Primary and secondary packaging under controlled containment
- Full CIP/SIP coverage and validated cleaning logic
Canaan Pharmaceutical Containment Equipments
Canaan provides comprehensive pharma containment solutions designed to support safe, compliant, and efficient pharmaceutical production. Our pharmaceutical containment solutions cover key solid dosage processes, from material dispensing to final dosage formation, integrating containment isolator systems with production equipment.
Containment isolator and flexible containment isolator systems for safe dispensing, weighing, and charging
High-containment capsule filling machines with dynamic sealing and OEB5-level performance
High-containment tablet presses with OEB5-level performance, precision control, and easy cleaning
High-containment granulation, drying, and coating equipment, engineered to minimize exposure during processing and material transfer
Each solution is engineered as part of a pharmaceutical containment system rather than a standalone machine, ensuring consistent containment performance across operations.
Capsule Filling
Learn MoreTableting
Learn MoreGranulation
Learn MoreGranulation Line
Learn MoreCoating
Learn MorePackaging
Learn MoreWhy Choose Canaan for High-Containment Solution
Canaan is a trusted provider of high-containment pharmaceutical manufacturing solutions, supported by:
- SMEPAC-tested and OEB5-certified containment performance
- Proven compliance with FDA and EMA expectations
- Strong project experience in highly potent API manufacturing
- Integrated design philosophy combining containment, automation, and cleanability
- End-to-end containment solutions across the full production line
- Canaan is one of the key drafters of China’s technical guidance documents on containment in pharmaceutical equipment.
By partnering with Canaan, pharmaceutical manufacturers gain a containment system supplier capable of supporting high-potency projects.
Get Expert Support